Search results
Weight loss drugs like Wegovy have taken the country by storm. But who can afford them?
USA TODAY via Yahoo Finance· 6 days agoIn the meantime, prices are extremely high for out-of-pocket purchases. Employers can't wait for ...
FTC Warns ‘Junk Patents’ Could Make Drugs Like Ozempic Pricier—Here’s How
Forbes· 1 day agoThe FTC sent warning letters to 10 pharmaceutical companies—including Novo Nordisk, AstraZeneca,...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
NBC Washington· 12 hours agoFederal regulators are challenging patents on 20 brand name drugs, including the blockbuster...
Novo Nordisk: Growth Is Still A Better Choice
GuruFocus.com via Yahoo Finance· 2 days agoSource: Author's elaboration, based on GuruFocus data. Novo Nordisk's trailing 12-month non-GAAP price-earnings ratio is 45.3, indicating it is trading...
Is Eli Lilly Stock A Buy After Weight-Loss Drug Crushes Quarterly Sales Forecasts?
Investor's Business Daily· 18 hours agoThose who stayed on Zepbound lost an additional 5.5% of their weight. In another analysis of...
Fauci to Testify; Doctor Survives Medical Plane Crash; Congressman Dies
MedPage Today· 6 days agoHealth news and commentary gathered by MedPage Today staff
Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie
Zacks via Yahoo Finance· 6 days agoIndustry's Current Valuation Based on the forward 12-month price-to-earnings (P/E), a commonly used...
Novo Nordisk Probed by Senate Committee on Weight-Loss Drug Prices
Morningstar· 7 days agoNovo Nordisk is being investigated by a U.S. Senate committee for the prices of its blockbuster weight-loss drugs Ozempic and Wegovy. Sen. Bernie Sanders (I., Vt.), chair of the Senate Committee ...
Sanders Launches Probe of 'Outrageously Overpriced' Ozempic and Wegovy | Common Dreams
CommonDreams.org· 6 days agoThe company makes semaglutide, a glucagon-like peptide-1 (GLP-1) agonist used to treat Type 2...